The 2017 MM&M Career & Salary Survey is open. Fill it out, and tell us about the latest salary and career trends in the pharma and healthcare sectors.
Novo Nordisk and Roche are two examples of drugmakers that are turning to digital-health startups to better engage with patients and mine valuable real-world evidence.
It's the third year of consecutive growth for spending on accredited CME, according to the Accreditation Council for Continuing Medical Education.
The FDA to study whether linking to risk information affects patient recall; patients view docs who take industry payments as less honest; Mallinckrodt ups political donations
McCann Health, Cannes Lions Healthcare Network of the Year, hosted a roundtable to discuss the role of creativity in a new world order where populism is undermining trust.
About 4.4 billion prescriptions filled in the U.S. in 2016; Sanofi and Ablynx reach I-O deal; biotech M&A slows in H1
The healthcare company released the documentary in minute-long snippets over a month, then debuted the full film this week.
Cost of throwing out expired drugs is $800 million per year; the FDA approves Gilead's new HCV drug; CDC says 1 in 10 Americans have diabetes
The 15-minute short film covers condom use, STIs, and safer sex positions for bodies that have become less flexible.
Novartis raises Alcon forecast; UDG acquires Cambridge BioMarketing; Spark Therapeutics receives priority review for Luxturna gene therapy
Publicis Health CEO Nick Colucci talks to MM&M about whether the AI tool will get U.S. and European creative directors to collaborate.
The Pikachu-catching phenomenon popularized AR and made the technology much more accessible.
More Americans are reporting medication errors; Public Citizen urges lawmakers to oppose off-label bills; BMS launches new I-O campaign
The FDA approves J&J psoriasis drug; PARP inhibitors are not cost-effective, ICER says; Verily releases mosquitoes to combat Zika
AstraZeneca CEO reportedly moving to Teva; the FDA reverses on approval for Amicus drug; Merck names winners of Alexa challenge
The drugmaker is one step closer to a potential approval of its experimental cancer treatment.
Former sales reps for Insys plead guilty to kickback allegations; digital health funding on the rise; PhRMA launches campaign about drug costs
How Huge and the New York Civil Liberties Union used lawmakers' own antiquated ideas to support the Reproductive Health Act.